跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,876 条关于
“refractory temporal lobe epilepsy”
全部
18,876
临床试验
15,740
药物
111
机构
35
资讯
2,990
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
uniQure's Gene Therapy AMT-260 Achieves 92% Seizure Reduction in First Drug-Resistant Epilepsy Patient
去年
uniQure Launches Public Offering to Advance Gene Therapy Pipeline
11个月前
UniQure Secures $175 Million Loan Facility to Support AMT-130 Gene Therapy Launch for Huntington's Disease
去年
uniQure Appoints Kylie O'Keefe as Chief Customer and Strategy Officer to Lead AMT-130 Commercialization for Huntington's Disease
去年
uniQure's AMT-130 Shows Promise in Huntington's Disease, FDA Meeting Scheduled
5个月前
UCB Acquires Neurona Therapeutics for $1.15 Billion to Advance Regenerative Cell Therapy for Drug-Resistant Epilepsy
4年前
First Patient Dosed in Groundbreaking Stem Cell Therapy Trial for Drug-Resistant Epilepsy Shows Dramatic Seizure Reduction
去年
Mayo Clinic Launches Groundbreaking Neural Cell Therapy Trial for Drug-Resistant Epilepsy
第 1 页，共 299 页
上一页
下一页
